← Back to the atlas
No. 1809Venture thesisMobility and logistics

In vivo CAR-T therapies could make one of medicine’s most sophisticated treatments far easier to deploy.

Source

Source thesis

DCVC discusses in-vivo CAR-T approaches intended to reduce the cost, waiting and specialised manufacturing associated with individually prepared cell therapies. The report includes Umoja as an example and describes investigational programmes; this is not evidence of general clinical availability or efficacy.